anti-Procalcitonin antibody product blog
Tags: Antibody; Procalcitonin; Monoclonal Antibody; anti-Procalcitonin antibody;
The Procalcitonin n/a (Catalog #MBS313024) is an Antibody produced from Host: Mouse. Hybridization of Sp2/0 myeloma cells with spleen cells from BALB/c mice.Source: Ascites and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Procalcitonin can be used in a range of immunoassay formats including, but not limited to, ELISA, Western Blot.
Suitable for use in ELISA and Western blot. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded. Researchers should empirically determine the suitability of the Procalcitonin n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Fragments of human Procalcitonin conjugated with carrier protein
Buffer: PBS, pH 7.4
Preservative: 0.1% Sodium azide. Affinity Constant: Not determined
Lyophylized: No
Warnings: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1 - 1.0 %. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Procalcitonin are readily searchable from our website. Different antibodies against the same target such as Procalcitonin may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.